A highly vancomycin-resistant laboratory mutant of Staphylococcus aureus

Area of Science:

• Microbiology
• Molecular Biology
• Biochemistry

Background:

• Vancomycin is a critical antibiotic for treating Gram-positive bacterial infections.
• Emergence of vancomycin resistance in bacteria poses a significant public health threat.
• Staphylococcus aureus is a common pathogen, and its resistance to vancomycin is a growing concern.

Purpose of the Study:

• To investigate the characteristics of a vancomycin-resistant Staphylococcus aureus mutant.
• To explore the mechanism of resistance and its impact on bacterial growth and cell wall synthesis.
• To differentiate this resistance from known vanA/vanB mediated resistance.

Main Methods:

• Induction of vancomycin resistance in Staphylococcus aureus through stepwise laboratory selection.
• Monitoring bacterial growth, cell division, and cell wall synthesis in the presence of vancomycin.
• Quantification of vancomycin concentration in culture medium using biological activity and High-Performance Liquid Chromatography (HPLC).
• Genetic analysis using vanA and vanB DNA probes and assessment of cell wall precursors.

Main Results:

• A vancomycin-resistant Staphylococcus aureus mutant with a high Minimum Inhibitory Concentration (MIC) was successfully generated.
• Inhibition of cell division, cell wall turnover, and autolysis was observed at high vancomycin concentrations, leading to multicellular clumps.
• Bacterial growth and normal morphology were restored as vancomycin concentration decreased below 1.0 µg/ml.
• The resistant mutant did not exhibit vanA or vanB genes and lacked detectable D-lactate cell wall precursors.

Conclusions:

• The study describes a novel vancomycin-resistant Staphylococcus aureus mutant.
• The resistance mechanism appears to involve inhibition of cell division and cell wall turnover, independent of known vanA/vanB genes.
• Further research is needed to elucidate the biochemical mechanism and clinical relevance of this observed resistance.